Current Drug Discovery Technologies
Title: Editorial [ Bio-Markers as Tools For Discovery of New Psoriasis Therapies ]
Volume: 9 Issue: 1
Author(s): Martin Braddock
Affiliation:
Export Options
About this article
Cite this article as:
Braddock Martin, Editorial [ Bio-Markers as Tools For Discovery of New Psoriasis Therapies ], Current Drug Discovery Technologies 2012; 9 (1) . https://dx.doi.org/10.2174/157016312799304534
DOI https://dx.doi.org/10.2174/157016312799304534 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
Related Journals
Related Books
19
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Heat Shock Protein 90 Inhibitors as Therapeutic Agents
Recent Patents on Anti-Cancer Drug Discovery MMP-9, a Potential Target for Cerebral Ischemic Treatment
Current Neuropharmacology Neopterin as a Marker for Immune System Activation
Current Drug Metabolism Anti-TNF and Crohns Disease: When Should we Start?
Current Drug Targets Inhibiting Protein-Protein Interactions as an Emerging Paradigm for Drug Discovery
Mini-Reviews in Medicinal Chemistry Peripheral Benzodiazepine Receptor (PBR) New Insight in Cell Proliferation and Cell Differentiation Review
Current Clinical Pharmacology Biologics as Treatment for Systemic Lupus: Great Efforts, Sobering Results, New Challenges
Current Drug Discovery Technologies Probiotics, Immune Function, Infection and Inflammation: A Review of the Evidence from Studies Conducted in Humans
Current Pharmaceutical Design Molecular-Targeted and Cell-Based Therapies for Sjogren’s Syndrome
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Phenylpyazoleanilides as Potent Inhibitor of IL-15 Dependent T Cell Proliferation. Part 2: Discovery of a New Drug Candidate, Y-320
Letters in Drug Design & Discovery Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
Current Drug Targets Role of Defensins and Cathelicidin LL37 in Auto-Immune and Auto- Inflammatory Diseases
Current Pharmaceutical Biotechnology Clinical Assessment of Autonomic Function in Fibromyalgia by the Refined and Abbreviated Composite Autonomic Symptom Score (COMPASS 31): A Case-Controlled Study
Reviews on Recent Clinical Trials Patent Annotations
Recent Patents on Anti-Infective Drug Discovery VEGF, Angiopoietin-1 and -2 in Bronchial Asthma: New Molecular Targets in Airway Angiogenesis and Microvascular Remodeling
Recent Patents on Inflammation & Allergy Drug Discovery Mouse Models of Primary Biliary Cirrhosis
Current Pharmaceutical Design Influence of the OATP Polymorphism on the Population Pharmacokinetics of Methotrexate in Chinese Patients
Current Drug Metabolism The Role of Parthenolide in Intracellular Signalling Processes: Review of Current Knowledge
Current Signal Transduction Therapy Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia
Current Drug Therapy Bioactivities of Iridoids
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry